(Q24195048)

7

object named as

Michael von Bergwelt-Baildon

0 references

Sebastian Theurich

4

object named as

Sebastian Theurich

0 references

Udo Holtick

1

object named as

Udo Holtick

0 references

author name string

Melanie Albrecht

2

0 references

Jens M Chemnitz

3

0 references

Christof Scheid

Cochrane Database of Systematic Reviews

6

0 references

publication date

20 April 2014

0 references

published in

0 references

cites work

Peripheral-blood stem cells versus bone marrow from unrelated donors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Hematopoietic-cell transplantation at 50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

The EBMT activity survey 2009: trends over the past 5 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Allogeneic transplantation: peripheral blood vs. bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Long-term safety of filgrastim (rhG-CSF) administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Donor selection for unrelated cord blood transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Assessing response of therapy for acute and chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis fro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

New perspectives on the biology of acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Quality of life after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

The allogeneic graft-versus-cancer effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Comorbidity burden in patients with chronic GVHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Blood versus marrow hematopoietic allogeneic graft

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Differences between graft product and donor side effects following bone marrow or stem cell donation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010189.PUB2

7 January 2021

10.1002/14651858.CD010189.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_v552ytcqqvhi5juk5htmex434a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v552ytcqqvhi5juk5htmex434a

24 November 2022